Argatroban: all 22 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO SupportRecruitingNCT06442267Phase 4
- Safety of Argatroban Infusion in Conduction DisturbancesCompletedNCT05740371Phase 4Results posted
- Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)TerminatedNCT04406389Phase 4Results posted
- Multi-arm Optimization of Stroke ThrombolysisCompletedNCT03735979Phase 3Results posted
- Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute StrokeTerminatedNCT01464788Phase 2Results posted
- Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft OcclusionTerminatedNCT01246011Phase 4Results posted
- Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery StentingCompletedNCT01163604Phase 4Results posted
- Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type IICompletedNCT00861692Phase 2Results posted
- Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)CompletedNCT00508924Phase 2Results posted
- Argatroban Stroke Treatment - A Pilot Safety StudyCompletedNCT00268762Phase 1/2Results posted
- Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMOCompletedNCT05226442Phase 2/3
- Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMOCompletedNCT04925167Not applicable
- Efficacy Argatroban in Ischemic Stroke With Early Deterioration (EASE)CompletedNCT04275180Phase 4
- Argatroban Plus R-tPA for Acute Ischemic StrokeCompletedNCT03740958Phase 4
- Thromboprophylaxis After Surgery for Gynecologic Malignancy in ChinaCompletedNCT02935530Phase 3
- Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in StrokeCompletedNCT02448069Phase 2
- Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery StentingCompletedNCT01980316Phase 4
- Argatroban in Critically Ill Patients With Heparin ResistanceCompletedNCT01734252Phase 2
- Argatroban Versus Lepirudin in Critically Ill PatientsTerminatedNCT00798525Phase 4
- Efficacy and Safety Study of Argatroban to Treat Heparin-Induced ThrombocytopeniaCompletedNCT00198588Phase 3
- Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to HeparinCompletedNCT00039858Phase 4
- Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing HemodialysisCompletedNCT00035178Phase 4